Sector updates in October
< 1 minute read
Investment funds
- Orbimed secured $3 billion across two new funds, OrbiMed Private Investments X and OrbiMed Asia Partners VI, to build leading healthcare companies
- Forbion secured €2.3 billion across two new funds, Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII, to invest in high potential biotechs
- TCGX secured $600 million for its Asia Life Sciences Fund I, to invest in Asian biotechs across different stages of development
Investors
- Marisol Quinero appointed Partner at Columbus Venture Partners
- Sandy Blin appointed Senior Investment Manager at Andera Partners
- Daniel Bode appointed Senior Associate at Angelini Ventures
- Jim Wilkinson appointed Chair of Oxford Seed Fund at Oxford Seed Fund
Analysts/Banking
- James Critchley appointed Co-Head EMEA Healthcare Investment Banking at Bank of America
Media
- Allison DeAngelis appointed Biotech and Pharmaceutical News Reporter at Bloomberg
- Will Maddox appointed Health Tech Deals Reporter at Axios (US)
- Mimi Billing left her role as Europe Editor at Sifted
- John Sterling left his role as Editor in Chief at Genetic Engineering & Biotechnology News
- Eric Sagonowsky has left Fierce Pharma
- Emma Pirnay appointed Health Reporter at POLITICO Europe
- Zaria Gorvett appointed Acting Health Features Editor at BBC News
- Russell Goldman appointed Lead News Editor, Science at The New York Times
- Judith Welikala appointed Senior Health Producer at ITV News
- Rory O’Neill appointed Global Health Reporter at Devex (US)
